iScience · 2026
Genetic diversity of the malaria vaccine candidate PfRIPR in a high transmission region of Senegal.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nair Megha, Geering Giselle, Agarwal Alyssa, Li Rebecca, Qiao Yujie, Xiao Qin, Pouye Mariama N, Thiam Laty G, Ba Aboubacar, Hagadorn Kelly A, Cisse Awa, Guerra Noemi, Tawaldemedhen Yome, Mangou Khadidiatou, Moore Adam J, Diallo Fatoumata, Sene Seynabou D, Sadio Bacary D, Zhang Elizabeth, Shapiro Lawrence, Patel Saurabh D, Mbengue Alassane, Vigan-Womas Ines, Sheng Zizhang, Bei Amy K
Аннотация
RH5-interacting protein (RIPR) is essential for the invasion of Plasmodium into host red blood cells and is currently being studied as a novel malaria vaccine candidate in Phase 1a clinical trials. To study the genetic diversity of RIPR, deep amplicon sequencing was used to identify RIPR mutations in Plasmodium falciparum clinical isolates (n = 89) collected in Kédougou, a high malaria transmission region of Senegal. We identified non-synonymous single-nucleotide polymorphisms (SNPs) in 64/89 (71.9%) of samples. In total, 26 non-synonymous SNPs were identified, including 15 novel SNPs. Sixteen of 26 SNPs could be threaded onto existing PfRIPR crystal structures to predict the effects of SNPs on RIPR stability. Seven of 16 mutations were predicted to destabilize PfRIPR, while two of 16 were predicted to increase the stability of RIPR. Additionally, we identified 3 SNPs (Q737K, T738K, and V840L) in the EGF5-8 domains of PfRIPR where neutralizing antibodies are known to bind.